<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="336680">
  <stage>Registered</stage>
  <submitdate>17/03/2011</submitdate>
  <approvaldate>24/03/2011</approvaldate>
  <actrnumber>ACTRN12611000310965</actrnumber>
  <trial_identification>
    <studytitle>Known difficult intubation: A randomised, prospective comparison of direct and videolaryngoscopy.</studytitle>
    <scientifictitle>Known difficult intubation: A randomised, prospective comparison of conventional intubation (Macintosh blade) or videolaryngoscope (A.P. Advance) to determine time to successful intubation, glottic view, ease of use and complications in patients with known difficult intubation.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Difficult Intubation</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Anaesthetics</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Patients will be randomised to receive either a conventional Macintosh blade or an A.P. Advance(trademark) videoscope using the Difficult Airway Blade.
The intervention (intubation using either the standard macintosh laryngoscope or the AP advance) will be a single event utilising standard intubating techniques (induction of anaesthesia and muscle relaxation) at the start of planned surgery requiring intubation.  The sole difference between the groups will be the type of laryngoscope used.
Duration of intervention will be less than 15 minutes</interventions>
    <comparator>Standard Macintosh Laryngoscope</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Time to intubation</outcome>
      <timepoint>at intervention</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Number of attempts at layngoscopy</outcome>
      <timepoint>at intervention</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Visual Analogue score of ease of use</outcome>
      <timepoint>immediately following intervention</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>View of glottic opening (Cormack and Lehane 1-4 with Macintosh blade) or 'Video-assited view' (full, partial, none)</outcome>
      <timepoint>at intervention</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Previous Cormack and Lehane grade 3 or 4 view at intubation.
Anticipated easy ventilation</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Anticipated need for Awake fiberoptic intubation by treating anaesthetist
Critical illness
Requirement for rapid sequence intubation</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Patients planned for intubation to facilitate their surgery will have previous anaesthetic records scanned for documentation regarding past Laryngoscopic view.
Those meeting inclusion criteria and lacking exclusion criteria will be invited to participate in the study.
Following provision of informed consent subjects will be allocated to one of the two treatment groups based on a predetermined, randomly generated treatment allocation list.
This list will be held in a secure location and the allocation assigned will be told to the treating doctors by a member of staff not directly involved in the trial.</concealment>
    <sequence>binary random number generation</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>18/04/2011</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Fremanlte Hospital</primarysponsorname>
    <primarysponsoraddress>Alma St,
Fremantle
WA
6160</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Fremantle Hospital</fundingname>
      <fundingaddress>Alma St,
Fremantle
WA
6160</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Venner SA, A Venner Group Company</fundingname>
      <fundingaddress>182-184 Stawell Street (PO Box 5250), Burnley Vic  3121</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The trial looks to establish if the use of a videolaryngoscope in patients with a known difficult airway makes intubation easier, faster and safer.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname />
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate>8/03/2011</ethicsubmitdate>
      <ethiccountry />
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Alex Swann</name>
      <address>Department of Anaesthesia
Fremantle Hospital
Alma St,
Fremantle
WA
6160</address>
      <phone>+61 8 9431 3333</phone>
      <fax />
      <email>alex.swann@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Alex Swann</name>
      <address>Department of Anaesthesia
Fremantle Hospital
Alma St,
Fremantle
WA
6160</address>
      <phone>+61 8 9431 3333</phone>
      <fax />
      <email>alex.swann@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Edmond O'Loughlin</name>
      <address>Department of Anaesthesia
Fremantle Hospital
Alma St,
Fremantle
WA
6160</address>
      <phone>+61 8 9431 3333</phone>
      <fax />
      <email>edmond.o'loughlin@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>